TANG CAPITAL PARTNERS LP 13D and 13G filings for Theseus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-16 4:00 pm Sale |
2024-02-14 | 13D | Theseus Pharmaceuticals, Inc. THRX |
TANG CAPITAL PARTNERS LP | 100 100.000% |
-3,254,926 (-100.00%) |
Filing |
| 2024-01-12 06:02 am Unchanged |
2024-01-09 | 13D | Theseus Pharmaceuticals, Inc. THRX |
TANG CAPITAL PARTNERS LP | 3,255,026 7.300% |
0 (Unchanged) |
Filing |
| 2023-12-28 06:00 am Purchase |
2023-12-22 | 13D | Theseus Pharmaceuticals, Inc. THRX |
TANG CAPITAL PARTNERS LP | 3,255,026 7.300% |
153,420 (+4.95%) |
Filing |
| 2023-11-24 1:49 pm Purchase |
2023-11-14 | 13D | Theseus Pharmaceuticals, Inc. THRX |
TANG CAPITAL PARTNERS LP | 3,101,606 7.000% |
3,101,606 (New Position) |
Filing |